» Articles » PMID: 8763269

Increased Serum Laminin and Angiogenin Concentrations in Patients with Peripheral Arterial Occlusive Disease

Overview
Journal J Clin Pathol
Specialty Pathology
Date 1996 Jun 1
PMID 8763269
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Aim: To measure serum laminin and angiogenin concentrations in patients with peripheral arterial occlusive disease (PAOD) Fontaine stages IIb, III, and IV.

Methods: The study population comprised 38 patients (20 men and 18 women) with stage IV PAOD, 11 patients (six men and five women) with stage III PAOD, 18 patients (10 men and eight women) with stage IIb PAOD, and 23 patients (10 men and 13 women) with deep vein thrombosis. Fifteen normal subjects (matched for risk factors) and 10 patients (five men and five women) without PAOD served as controls. Serum samples were obtained at admission and serum laminin and angiogenin concentrations were measured using an enzyme linked immunosorbent assay.

Results: Patients with stage IV PAOD had higher serum laminin (mean +/- SEM; 826 +/- 97 ng/ml) and angiogenin concentrations (467 +/- 26 pg/ml) than normal subjects (laminin: 379 +/- 21 ng/ml; angiogenin: 358 +/- 16 pg/ml) and patients without PAOD (laminin: 277 +/- 34 ng/ml; angiogenin: 406 +/- 25 pg/ml). A significant correlation was found between angiogenin and laminin and between serum laminin and fibrinogen concentrations in patients with stage IV disease.

Conclusions: Raised laminin and angiogenin concentrations may be indicators of endothelial damage caused by reduced vascular perfusion or compensatory revascularisation, or both.

Citing Articles

Angiogenin Levels and Carotid Intima-Media Thickness in Patients with Type 1 Diabetes and Metabolic Syndrome.

Neubauer-Geryk J, Wielicka M, Kozera G, Bieniaszewski L Biomedicines. 2023; 11(9).

PMID: 37761032 PMC: 10526946. DOI: 10.3390/biomedicines11092591.


Angiogenin-A Proposed Biomarker for Cardiovascular Disease-Is Not Associated With Long-Term Survival in Patients With Peripheral Artery Disease.

Hobaus C, Pesau G, Zierfuss B, Koppensteiner R, Schernthaner G Angiology. 2021; 72(9):855-860.

PMID: 33779308 PMC: 8436295. DOI: 10.1177/00033197211004393.


GSTM1 Modulates Expression of Endothelial Adhesion Molecules in Uremic Milieu.

Jerotic D, Suvakov S, Matic M, Alqudah A, Grieve D, Pljesa-Ercegovac M Oxid Med Cell Longev. 2021; 2021:6678924.

PMID: 33574979 PMC: 7860968. DOI: 10.1155/2021/6678924.


Three decades of research on angiogenin: a review and perspective.

Sheng J, Xu Z Acta Biochim Biophys Sin (Shanghai). 2015; 48(5):399-410.

PMID: 26705141 PMC: 4888354. DOI: 10.1093/abbs/gmv131.


Niaspan attenuates the adverse effects of bone marrow stromal cell treatment of stroke in type one diabetic rats.

Yan T, Ye X, Chopp M, Zacharek A, Ning R, Venkat P PLoS One. 2013; 8(11):e81199.

PMID: 24303036 PMC: 3841133. DOI: 10.1371/journal.pone.0081199.


References
1.
Szirmai I, Kamondi A, Magyar H, Juhasz C . Relation of laboratory and clinical variables to the grade of carotid atherosclerosis. Stroke. 1993; 24(12):1811-6. DOI: 10.1161/01.str.24.12.1811. View

2.
Ribatti D, Vacca A, Roncali L, Dammacco F . Angiogenesis under normal and pathological conditions. Haematologica. 1991; 76(4):311-20. View

3.
Parise E, Rosa H . Serum laminin in hepatosplenic human schistosomiasis. Mem Inst Oswaldo Cruz. 1992; 87 Suppl 4:127-8. DOI: 10.1590/s0074-02761992000800018. View

4.
Ernst E . Fibrinogen as a cardiovascular risk factor--interrelationship with infections and inflammation. Eur Heart J. 1993; 14 Suppl K:82-7. View

5.
Hasselbalch H, Junker P . Serum laminin P1 in idiopathic myelofibrosis and related diseases. Leuk Res. 1994; 18(8):623-8. DOI: 10.1016/0145-2126(94)90044-2. View